Compare CLPT & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLPT | TRTX |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 554.2M | 659.4M |
| IPO Year | 2009 | N/A |
| Metric | CLPT | TRTX |
|---|---|---|
| Price | $18.58 | $8.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $20.00 | $9.83 |
| AVG Volume (30 Days) | ★ 892.4K | 698.7K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 11.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,971,000.00 | N/A |
| Revenue This Year | $45.67 | $8.78 |
| Revenue Next Year | $19.51 | $4.14 |
| P/E Ratio | ★ N/A | $14.82 |
| Revenue Growth | ★ 17.78 | N/A |
| 52 Week Low | $8.27 | $7.57 |
| 52 Week High | $30.10 | $9.85 |
| Indicator | CLPT | TRTX |
|---|---|---|
| Relative Strength Index (RSI) | 66.53 | 46.79 |
| Support Level | $12.55 | $8.35 |
| Resistance Level | $27.64 | $8.72 |
| Average True Range (ATR) | 1.47 | 0.15 |
| MACD | 0.17 | -0.02 |
| Stochastic Oscillator | 86.13 | 30.61 |
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.